1. Home
  2. PHIO vs HSDT Comparison

PHIO vs HSDT Comparison

Compare PHIO & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHIO
  • HSDT
  • Stock Information
  • Founded
  • PHIO 2011
  • HSDT N/A
  • Country
  • PHIO United States
  • HSDT United States
  • Employees
  • PHIO N/A
  • HSDT N/A
  • Industry
  • PHIO Biotechnology: Pharmaceutical Preparations
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PHIO Health Care
  • HSDT Health Care
  • Exchange
  • PHIO Nasdaq
  • HSDT Nasdaq
  • Market Cap
  • PHIO 13.5M
  • HSDT 707.6M
  • IPO Year
  • PHIO N/A
  • HSDT N/A
  • Fundamental
  • Price
  • PHIO $2.10
  • HSDT $7.88
  • Analyst Decision
  • PHIO Strong Buy
  • HSDT Hold
  • Analyst Count
  • PHIO 3
  • HSDT 1
  • Target Price
  • PHIO $10.67
  • HSDT N/A
  • AVG Volume (30 Days)
  • PHIO 135.3K
  • HSDT 1.0M
  • Earning Date
  • PHIO 11-13-2025
  • HSDT 11-11-2025
  • Dividend Yield
  • PHIO N/A
  • HSDT N/A
  • EPS Growth
  • PHIO N/A
  • HSDT N/A
  • EPS
  • PHIO N/A
  • HSDT N/A
  • Revenue
  • PHIO N/A
  • HSDT $295,000.00
  • Revenue This Year
  • PHIO N/A
  • HSDT N/A
  • Revenue Next Year
  • PHIO N/A
  • HSDT $75.13
  • P/E Ratio
  • PHIO N/A
  • HSDT N/A
  • Revenue Growth
  • PHIO N/A
  • HSDT N/A
  • 52 Week Low
  • PHIO $0.97
  • HSDT $5.37
  • 52 Week High
  • PHIO $9.79
  • HSDT $1,200.00
  • Technical
  • Relative Strength Index (RSI)
  • PHIO 40.80
  • HSDT 36.04
  • Support Level
  • PHIO $2.07
  • HSDT $13.85
  • Resistance Level
  • PHIO $2.45
  • HSDT $16.81
  • Average True Range (ATR)
  • PHIO 0.12
  • HSDT 2.44
  • MACD
  • PHIO -0.03
  • HSDT -1.16
  • Stochastic Oscillator
  • PHIO 4.06
  • HSDT 0.71

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

About HSDT Helius Medical Technologies Inc. (DE)

Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.

Share on Social Networks: